Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-000708
Accepted
2021-02-24 00:15:06
Documents
1
Effectiveness Date
2021-02-23
Registration Form
F-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 597
  Complete submission text file 9999999995-21-000708.txt   1830
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: EFFECT | Act: 33 | File No.: 333-234292 | Film No.: 21668340
SIC: 2834 Pharmaceutical Preparations